Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen and Hitachi Enter into an Agreement

Published: Thursday, October 17, 2013
Last Updated: Thursday, October 17, 2013
Bookmark and Share
The companies to develop offering that combines Whole Genome Mapping™ with cloud-based informatics and data management platforms.

OpGen, Inc. and Hitachi High-Technologies Corporation today announced an agreement to develop a comprehensive human chromosome mapping analytical service for clinical research applications by a combination of OpGen’s market-leading Whole Genome Mapping™ technology and Hitachi High-Technologies’ and Hitachi group’s cloud-based systems. This service will include bioinformatics tools to complete human genome sequence, and detect and analyze structural variations in human chromosomes. 

“Hitachi High-Technologies Corporation is a global technology leader, and we are pleased to partner with them to create an integrated solution for human genome analysis that captures important structural variation information,” said Douglas White, chief executive officer of OpGen, Inc. “The resulting human chromosome mapping service will enable OpGen to continue its expansion into clinical research with the potential to develop diagnostic applications for diseases based on a patient’s genetic information.” 

Under the terms of this agreement, Hitachi High-Technologies will fund development, and the companies will work together to combine the strengths of their proprietary technologies. OpGen’s Whole Genome Mapping provides a unique view into structural variation in human chromosomes and offers a more accurate and complete analysis of the human genome than next generation sequencing data alone can provide. Many structural variations are associated with cancer, autism, Alzheimer’s disease and many other cognitive disorders. This type of genetic information will enable development of new therapies, and eventually will empower the broader healthcare community to diagnose and guide treatment decisions based on a patient’s genetic profile. 

Hitachi High-Technologies, with recognized experience and achievements through DNA sequencer business in the life science and translational research markets, has been developing the cloud platform for human genome data analysis with Hitachi Solutions, in Foster City, California. The human genome cloud platform will enable secure entry portals for researchers, clinicians, and eventually patients to access Whole Genome Mapping data, human chromosome analytical tools and ultimately, clinically actionable data. As part of the service, Hitachi High-Technologies also will add human DNA sequence analytical tools, which complement Whole Genome Mapping, to provide complete genetic evaluation of human chromosomes.

“This partnership leverages our development of the cloud-based informatics platform and provides enabling and proven technology for human genetic analysis,” said Takashi Matsuzaka, senior vice president and executive officer, CTO of Hitachi High-Technologies Corporation. “This is a great example of how Hitachi High-Technologies is continuously enhancing our healthcare informatics offerings for customers worldwide by partnering our technologies with other innovative companies, such as OpGen.”

OpGen and Hitachi High-Technologies/Hitachi Solutions plan to introduce more details about the service in the Hitachi booths 811 & 813 at the American Society of Human Genetics Annual Meeting, being held October 23-25 in Boston.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen Assists 100K Genome Project
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.
Thursday, December 20, 2012
OpGen Announces Formation of Public Health Consortium
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.
Friday, May 18, 2012
OpGen Announces Strategic Collaboration with IQT
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.
Tuesday, May 01, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
OpGen Receives Frost & Sullivan New Product Innovation Award
OpGen, Inc. announces the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation for their Whole Genome Mapping System.
Wednesday, August 24, 2011
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!